NDA[removed]S-024 Page 3

First Page		Document Content
Date: 2010-01-24 19:47:26 Medicine Loop diuretics Indoles Amides Bumetanide Furosemide Diuretic Indometacin Ascites Chemistry Organic chemistry Organochlorides		NDA[removed]S-024 Page 3 Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 67,97 KB Share Document on Facebook

	Press Release Sequana Medical AG raises CHF 23 million in a Series C financing led by LSP, and adds an Independent Board Chairman and Vice President of Sales and Marketing. Zurich, SWITZERLAND - 28 April 2014 DocID: 1rcGW - View Document
	Press Release ® Sequana Medical receives CE-mark approval for the use of its alfapump system in cancer patients with malignant ascites Zürich, SWITZERLAND – 30. Oct, 2012 DocID: 1gPDh - View Document
	Microsoft PowerPoint - PD_in_Special_Populations DocID: 1gE0h - View Document
	Editorial The clinical course of cirrhosis. Population based studies and the need of personalized medicine Gennaro D’Amico Ospedale V Cervello, Palermo, Italy DocID: 1gBX1 - View Document
	Microsoft PowerPoint - Encapsulating Peritoneal Sclerosis Hansson April 2011 DocID: 1gj5v - View Document